<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-52fc-3a32-0153-57db4dd91c87</uuid><title>Venous Thromboembolism Patients with Anticoagulation Overlap Therapy</title><shortTitle>CMS73</shortTitle><emeasureid>73</emeasureid><guid>6f069bb2-b3c4-4bf4-adc5-f6dd424a10b7</guid><version>5.1.000</version><nqfid extension="0373" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3cd1-4954-013c-f32c3ab70ca1"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="1.3.6.1.4.1.33895">The Joint Commission</steward><developers><developer id="1.3.6.1.4.1.33895">The Joint Commission</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>This measure assesses the number of patients diagnosed with confirmed VTE who received an overlap of parenteral (intravenous [IV] or subcutaneous [subcu]) anticoagulation and warfarin therapy. For patients who received less than five days of overlap therapy, they should be discharged on both medications or have a reason for discontinuation of overlap therapy. Overlap therapy should be administered for at least five days with an international normalized ratio (INR) greater than or equal to 2 prior to discontinuation of the parenteral anticoagulation therapy, discharged on both medications or have a reason for discontinuation of overlap therapy.</description><copyright>Measure specifications are in the Public Domain.

LOINC(R) is a registered trademark of the Regenstrief Institute.

This material contains SNOMED Clinical Terms (R) (SNOMED CT[C]) copyright 2004-2015 International Health Terminology Standards Development Organization. All rights reserved.</copyright><disclaimer>These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty.</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount><elementRef dataType="Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" name="Encounter Inpatient" oid="2.16.840.1.113883.3.666.5.307"/></itemCount><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>For patients who present with a confirmed acute VTE, parenteral anticoagulation is the first line of therapy because of its rapid onset of action (Buller et al., 2004).  Warfarin can be initiated on the first day of treatment after the first dose of a parenteral anticoagulant has been given. Because the warfarin has a very slow onset of action, it cannot be used as mono-therapy for acute VTE (Ansell et al., 2008). 

The strong (Level I) recommendations to overlap parenteral anticoagulation with oral warfarin therapy in the initial treatment of VTE events is based in part on the known effect of warfarin on the coagulation cascade (Brandjes, et al.,1992). The early increase in the Pro thrombin time (PT) and INR often reflects the laboratory finding of initial reduction in clotting factors of the extrinsic pathway of coagulation resulting in prolongation of the PT/INR, while the patient is still at risk of thromboembolic events due to persistent levels of coagulation factors of the intrinsic pathway and common pathways of coagulation.

The recommendation that heparins and warfarin overlap for a five-day period is based on pharmacokinetic, pharmacologic, pathophysiologic, and clinical evidence as noted by Wittkowsky A.K. (2005). All studies support the pharmacokinetic characteristics of warfarin and the time delay in achieving an antithrombotic effect suggesting the need for overlap of heparin during initial warfarin dosing in order to prevent thrombus extension, embolization to the lungs, death due to Pulmonary Emboli (PE), and the development of complications such as recurrent thromboembolic events and the postthrombotic syndrome. Kearon et al, 2008 also denotes current recommendation for treatment of confirmed VTE to begin with oral warfarin therapy, with combination of initial anticoagulation therapy for a minimum of 5 days and until the INR is &gt;2.0 for at least 24 hours, and then a recommended target rate.</rationale><recommendations>Overlap therapy of both warfarin and parenteral therapy is the recommended treatment for VTE patients if there are no contraindications. This therapy should take place over five or more days, until an INR greater than or equal to 2.0 is reached prior to discontinuation of parenteral therapy.</recommendations><improvementNotations>Improvement noted as an increase in the rate</improvementNotations><references><reference>Ansell J, Hirsch J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: The Eighth ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2008 133:160S-198S.</reference><reference>Brandjes DP, Heijboer H, Buller HR, et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1992; 327:1485-9.</reference><reference>Guyatt, G.H., Akl, E.A., Crowther, M., Gutterman, D., Schunemann, H. Antithromboitic Therapy and Prevention of Thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141(2) (Supp):7S-47S.</reference><reference>Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb; 141(2 Suppl):e419S-94S.  </reference><reference>Wittkowsky AK. Why warfarin and heparin need to overlap when treating acute venous thromboembolism. Dis Mon 2005; 51:112-115.</reference></references><definitions>None</definitions><guidance>CMS recognizes the difficulty in capturing the VTE confirmed concept required in this measure and suggests eligible hospitals participating in the Medicare &amp; Medicaid EHR Incentive Programs consider selecting alternative electronic clinical quality measures (eCQMs) to meet program requirements for meaningful use. If suitable alternatives are unavailable, CMS will accept a 0 denominator submission for the eCQM version only for this measure. 

In the numerator logic, overlap therapy duration uses four days (instead of five) as a threshold because the subtraction doesn't take into account one of the dates. For example, for a patient started on overlap therapy on 01/01/2016 who was last administered a parenteral anticoagulant on 01/05/2016, the difference between the dates is 4 days, but the number of days the patient was on overlap therapy was 5.

The denominator logic identifies the first confirmatory VTE diagnostic test because there are logic criteria dependent on the timing of the initial confirmation of the VTE diagnosis. Subsequent references to the VTE diagnostic test use occurrencing to ensure that the first confirmatory VTE diagnostic test is consistently used throughout the logic.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>Patients age 18 and older discharged from hospital inpatient acute care during the measurement period with a length of stay less than or equal to 120 days and a diagnosis of venous thromboembolism (VTE)</initialPopDescription><denominatorDescription>Patients with VTE confirmed through a diagnostic test who received warfarin</denominatorDescription><denominatorExclusionsDescription>* Patients with comfort measures documented
* Patients discharged to a health care facility for hospice care
* Patients discharged to home for hospice care
* Patients who expired
* Patients who left against medical advice
* Patients discharged to an acute care facility</denominatorExclusionsDescription><numeratorDescription>Patients who received overlap therapy (warfarin and parenteral anticoagulation):

* Five or more days, with an INR greater than or equal to 2 prior to discontinuation of parenteral therapy OR
* Five or more days, with an INR less than 2 and discharged on overlap therapy OR
* Less than five days and discharged on overlap therapy OR
* With documentation of reason for discontinuation of parenteral therapy OR
* With documentation of a reason for no overlap therapy</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex</supplementalData><qualityMeasureSet uuid="363e8228-7459-41be-93b8-c17a3583ce18">eMeasure Venous Thromboembolism (eVTE)</qualityMeasureSet>
<finalizedDate value="201603081432-0600"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3cd1-4954-013c-f32c3ab60c90" name="ONC Administrative Sex"/><elementRef id="40280381-3cd1-4954-013c-f32c3ab60c91" name="Race"/><elementRef id="40280381-3cd1-4954-013c-f32c3ab60c92" name="Ethnicity"/><elementRef id="40280381-3cd1-4954-013c-f32c3ab60c93" name="Payer"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="Occurrence A of $EncounterInpatient" instance="A" instanceOf="9A84ECC9-EB45-482D-80E8-19638D05FD48" qdmVariable="true" uuid="EC8AD17C-445E-40BA-B6F0-882B4537047E"><functionalOp displayName="Satisfies All" type="SATISFIES ALL"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="63111D19-454B-4D90-8382-BDCB9D2E03AA" comparisonValue="120" mode="Less Than Or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="Ends During" type="EDU"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3cd1-4954-013c-f32c3ab70ca1" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="Age GTET 18 years at Occ A EncIP" qdmVariable="false" uuid="500739A7-45F8-404D-BC27-D96B3DF61AB6"><functionalOp displayName="Age&gt;= 18 years at" operatorType="Greater Than or Equal To" quantity="18" type="AGE AT" unit="years"><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></functionalOp></subTree><subTree displayName="DiagnosisVTE" qdmVariable="true" uuid="D25F0D60-FF24-481D-B6FE-0C4617C1F5BC"><setOp displayName="Union" type="union"><elementRef displayName="Venous Thromboembolism : Diagnosis" id="aedc882e-f4cc-4e9c-afba-dde0ea78e4b3" type="qdm"/><elementRef displayName="Obstetrics VTE : Diagnosis" id="c81556a5-e3f3-4c14-a115-e28ba756a517" type="qdm"/></setOp></subTree><subTree displayName="Dx Thrombocytopenia LTET 1 d SAS MOST RECENT Med Adm Parenteral Anti" qdmVariable="false" uuid="4040A75C-C4EF-4C11-ADA7-9C1853192D70"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><elementRef displayName="Thrombocytopenia : Diagnosis" id="3caf509c-8833-48da-a585-ee72b0041c1a" type="qdm"/><elementRef displayName="Occurrence A of Parenteral Anticoagulant : Medication, Administered" id="e60a430e-e701-4aab-86a0-8c6948476ef9" type="qdm"/></relationalOp></subTree><subTree displayName="DxVTE variable starts during ED visit LTET 1hr EBOCW OccA Inpt variable" qdmVariable="false" uuid="63D2B97D-8934-4008-A3C0-63B61D2B20EE"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="DiagnosisVTE" id="D25F0D60-FF24-481D-B6FE-0C4617C1F5BC" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></subTree><subTree displayName="DxVTE variable starts during Occ A EncIP" qdmVariable="false" uuid="E88B40CF-48AE-447A-B453-98F679BA6016"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="DiagnosisVTE" id="D25F0D60-FF24-481D-B6FE-0C4617C1F5BC" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp></subTree><subTree displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" qdmVariable="false" uuid="21BCFFC9-3A52-49D5-AA92-8A3608FA874D"><relationalOp displayName="&lt;= 1 hours Ends Before Or Concurrent With Start Of" operatorType="Less Than or Equal To" quantity="1" type="EBSORECWS" unit="hours"><elementRef displayName="Emergency Department Visit : Encounter, Performed" id="65446d24-a0d1-4ce5-940a-419a95bfff23" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp></subTree><subTree displayName="EncounterInpatient" qdmVariable="true" uuid="9A84ECC9-EB45-482D-80E8-19638D05FD48"><functionalOp displayName="Satisfies All" type="SATISFIES ALL"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="c9271f0c-7b9d-41e0-a722-d2867698a51a" comparisonValue="120" mode="Less Than Or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="Ends During" type="EDU"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3cd1-4954-013c-f32c3ab70ca1" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="FIRST Union of MedWar st dur EncIP ED Visit GTET 4d SBS MOST RECENT Union" qdmVariable="false" uuid="93F8D495-6B7A-42E1-ADBB-E26F90B5A6AE"><relationalOp displayName="&gt;= 4 days Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="4" type="SBS" unit="days"><functionalOp displayName="First" type="FIRST"><setOp displayName="Union" type="union"><subTreeRef displayName="MedicationWarfarinParenteralAnticoagulantOverlap starts during OccA Enc IP" id="BDBB235A-EBC3-4328-9EF1-0B4CAAF7D865" type="subTree"/><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="MedicationWarfarinParenteralAnticoagulantOverlap" id="EC71E319-A70D-490E-A680-163D3FFABCA7" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></setOp></functionalOp><functionalOp displayName="Most Recent" type="MOST RECENT"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of Parenteral Anticoagulant : Medication, Administered" id="e60a430e-e701-4aab-86a0-8c6948476ef9" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp></functionalOp></relationalOp></subTree><subTree displayName="FIRST Union of MedWar starts during EncIP ED LT 4d SBS MRECENT Union Med" qdmVariable="false" uuid="216AB0CC-F366-4AA4-858B-94C801E8CCD3"><relationalOp displayName="&lt; 4 days Starts Before Start Of" operatorType="Less Than" quantity="4" type="SBS" unit="days"><functionalOp displayName="First" type="FIRST"><setOp displayName="Union" type="union"><subTreeRef displayName="MedicationWarfarinParenteralAnticoagulantOverlap starts during OccA Enc IP" id="BDBB235A-EBC3-4328-9EF1-0B4CAAF7D865" type="subTree"/><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="MedicationWarfarinParenteralAnticoagulantOverlap" id="EC71E319-A70D-490E-A680-163D3FFABCA7" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></setOp></functionalOp><functionalOp displayName="Most Recent" type="MOST RECENT"><setOp displayName="Union" type="union"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of Parenteral Anticoagulant : Medication, Administered" id="e60a430e-e701-4aab-86a0-8c6948476ef9" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of Parenteral Anticoagulant : Medication, Administered" id="e60a430e-e701-4aab-86a0-8c6948476ef9" type="qdm"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></setOp></functionalOp></relationalOp></subTree><subTree displayName="Intersection of OccA EncIP EncPerf Enc IP sat any DC statuses" qdmVariable="false" uuid="644705E0-1F14-4EB5-B68F-FC099CF937C9"><setOp displayName="Intersection" type="intersection"><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/><functionalOp displayName="Satisfies Any" type="SATISFIES ANY"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="be1e7ad8-9d3b-4df2-9dfb-1a4d7f5383d9" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013c-f32c3ab70caa"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="1c23646a-4d74-47fa-9c1e-7201f2901c3b" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013c-f32c3ab60c9f"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="229959ad-dfd3-4edc-a9d9-f9e04ba84157" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013c-f32c3ab80cb2"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="7c0cd91a-e398-452c-b5b6-98d35d785e09" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013c-f32c3ab60c9e"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="039bc0be-6f57-48ae-899a-93dfd7b6a595" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013c-f32c3ab70cab"/></elementRef></functionalOp></setOp></subTree><subTree displayName="InterventionComfortMeasures" qdmVariable="true" uuid="7702BCAB-4E34-48C6-9888-8E97CD809CE7"><setOp displayName="Union" type="union"><elementRef displayName="Comfort Measures : Intervention, Order" id="f04dbcdd-fbb8-43d2-b8a7-66d008530eeb" type="qdm"/><elementRef displayName="Comfort Measures : Intervention, Performed" id="f5ab7743-11b1-4f73-99d4-87dfcfd859d3" type="qdm"/></setOp></subTree><subTree displayName="InterventionComfortMsrs starts during Occ A ED Visit" qdmVariable="false" uuid="9A2FA752-2C19-4955-A1C3-16982A14EB8E"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="InterventionComfortMeasures" id="7702BCAB-4E34-48C6-9888-8E97CD809CE7" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></subTree><subTree displayName="InterventionComfortMsrs starts during Occ A EncIP" qdmVariable="false" uuid="741AE926-174D-44F6-87FE-6E6A2169C518"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="InterventionComfortMeasures" id="7702BCAB-4E34-48C6-9888-8E97CD809CE7" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp></subTree><subTree displayName="Lab Test Perf INR result GTET 2 LTET 1d SAS OccA Med Adm Parent" qdmVariable="false" uuid="539F3E7F-C806-4BB8-8BC9-DA2E13D4648C"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><elementRef displayName="INR : Laboratory Test, Performed" id="40280381-3cd1-4954-013c-f32c3ab60c9d" type="qdm"><attribute attrUUID="18cac123-15f4-4cd2-8c86-b91c62abf0bd" comparisonValue="2.0" mode="Greater Than Or Equal To" name="result"/></elementRef><elementRef displayName="Occurrence A of Parenteral Anticoagulant : Medication, Administered" id="e60a430e-e701-4aab-86a0-8c6948476ef9" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf INR result LT 2 LTET 1d SAS OccA Med Adm Parenter" qdmVariable="false" uuid="E124972F-CCA1-4B61-9CEF-6533915448C0"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><elementRef displayName="INR : Laboratory Test, Performed" id="40280381-3cd1-4954-013c-f32c3ab60c9d" type="qdm"><attribute attrUUID="dc74ef87-cf89-4c34-bc0b-7bca609a507c" comparisonValue="2.0" mode="Less Than" name="result"/></elementRef><elementRef displayName="Occurrence A of Parenteral Anticoagulant : Medication, Administered" id="e60a430e-e701-4aab-86a0-8c6948476ef9" type="qdm"/></relationalOp></subTree><subTree displayName="Med Adm Warfarin sat any starts during Occ A EncIP starts during ED EBS IP" qdmVariable="false" uuid="EB09CF1C-D186-4066-9D69-C9ADE3663883"><functionalOp displayName="Satisfies Any" type="SATISFIES ANY"><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb5" type="qdm"/><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb5" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb5" type="qdm"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></functionalOp></subTree><subTree displayName="MedicationReasonForNoParenteralAnticoagulant" qdmVariable="true" uuid="CFDB1DA3-3B3A-4F97-8E50-CFF72600B8F5"><setOp displayName="Union" type="union"><elementRef displayName="Parenteral anticoagulant ingredient specific : Medication, Order" id="65a58dbd-4e61-430f-8ba0-cc582ae653c3" type="qdm"><attribute attrUUID="252e02a5-a06e-4cbc-8d55-e1dee182e504" mode="Value Set" name="negation rationale" qdmUUID="40280381-3cd1-4954-013c-f32c3ab70ca6"/></elementRef><elementRef displayName="Parenteral anticoagulant ingredient specific : Medication, Order" id="65a58dbd-4e61-430f-8ba0-cc582ae653c3" type="qdm"><attribute attrUUID="52b473f3-87e3-4fb7-9939-110a4f18013a" mode="Value Set" name="negation rationale" qdmUUID="40280381-3cd1-4954-013c-f32c3ab70ca7"/></elementRef></setOp></subTree><subTree displayName="MedicationReasonForNoParenteralAnticoagulantAtDischarge" qdmVariable="true" uuid="1A77071B-8E1D-4C03-BDDC-42B5D884BB63"><setOp displayName="Union" type="union"><elementRef displayName="Parenteral anticoagulant ingredient specific : Medication, Discharge" id="b6e95aa0-55d9-4978-84dd-2e941614a65a" type="qdm"><attribute attrUUID="bb83d958-3eba-4516-bd37-24526006ca1b" mode="Value Set" name="negation rationale" qdmUUID="40280381-3cd1-4954-013c-f32c3ab70ca6"/></elementRef><elementRef displayName="Parenteral anticoagulant ingredient specific : Medication, Discharge" id="b6e95aa0-55d9-4978-84dd-2e941614a65a" type="qdm"><attribute attrUUID="3bd15bc8-61e4-47e7-b0f3-cc6d6af22cea" mode="Value Set" name="negation rationale" qdmUUID="40280381-3cd1-4954-013c-f32c3ab70ca7"/></elementRef></setOp></subTree><subTree displayName="MedicationReasonForNotAdministeringParenteralAnticoagulantDose" qdmVariable="true" uuid="88813EB0-DEE1-4F31-B3F2-C9E3423C1803"><setOp displayName="Union" type="union"><elementRef displayName="Parenteral Anticoagulant : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb4" type="qdm"><attribute attrUUID="8cb2a1b9-3346-4464-a549-3c6d4eae077f" mode="Value Set" name="negation rationale" qdmUUID="40280381-3cd1-4954-013c-f32c3ab70ca6"/></elementRef><elementRef displayName="Parenteral Anticoagulant : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb4" type="qdm"><attribute attrUUID="df85ca7f-47dd-4bcc-aaed-64f92c89bc8a" mode="Value Set" name="negation rationale" qdmUUID="40280381-3cd1-4954-013c-f32c3ab70ca7"/></elementRef></setOp></subTree><subTree displayName="MedicationWarfarinParenteralAnticoagulantOverlap" qdmVariable="true" uuid="EC71E319-A70D-490E-A680-163D3FFABCA7"><setOp displayName="Union" type="union"><relationalOp displayName="&lt; 1 days Starts After Start Of" operatorType="Less Than" quantity="1" type="SAS" unit="days"><elementRef displayName="Parenteral Anticoagulant : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb4" type="qdm"/><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb5" type="qdm"/></relationalOp><relationalOp displayName="&lt; 1 days Starts Before Start Of" operatorType="Less Than" quantity="1" type="SBS" unit="days"><elementRef displayName="Parenteral Anticoagulant : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb4" type="qdm"/><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb5" type="qdm"/></relationalOp></setOp></subTree><subTree displayName="MedicationWarfarinParenteralAnticoagulantOverlap starts during OccA Enc IP" qdmVariable="false" uuid="BDBB235A-EBC3-4328-9EF1-0B4CAAF7D865"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="MedicationWarfarinParenteralAnticoagulantOverlap" id="EC71E319-A70D-490E-A680-163D3FFABCA7" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp></subTree><subTree displayName="Occ A Diag Study Perf VTE Diag Test during Occ A EncIP" qdmVariable="false" uuid="145B9987-7FDE-44E0-B94E-BBD9B729E12A"><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp></subTree><subTree displayName="Occ A Diag Study Perf VTE Diag Test LTET 4d SBS Occ A EncIP" qdmVariable="false" uuid="9D361F6D-83AB-4854-80E4-3216E09C2909"><relationalOp displayName="&lt;= 4 days Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="days"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp></subTree><subTree displayName="Occ A Diag Study Perf VTE Diag Test starts during Occ A ED Visit" qdmVariable="false" uuid="B2B30E99-1008-4355-A921-B128D0EF1322"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></subTree><subTree displayName="OccA DiagStudyPerf VTE Diag Test LTET 4d SBS Occ A ED LTET 1hr EBOCWSO Inpt" qdmVariable="false" uuid="AA830D78-2FB0-4089-A875-F60B75643F8C"><relationalOp displayName="&lt;= 4 days Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="days"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></subTree><subTree displayName="Union of Med DC ParenAnti MedRsnForNoParAntiDC starts during EncIP SAS" qdmVariable="false" uuid="C201AF97-68E1-4E02-B6CB-E40698C800C8"><setOp displayName="Union" type="union"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Parenteral Anticoagulant : Medication, Discharge" id="40280381-3cd1-4954-013c-f32c3ab80cbe" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="MedicationReasonForNoParenteralAnticoagulantAtDischarge" id="1A77071B-8E1D-4C03-BDDC-42B5D884BB63" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><subTreeRef displayName="MedicationReasonForNotAdministeringParenteralAnticoagulantDose" id="88813EB0-DEE1-4F31-B3F2-C9E3423C1803" type="subTree"/><elementRef displayName="Occurrence A of Parenteral Anticoagulant : Medication, Administered" id="e60a430e-e701-4aab-86a0-8c6948476ef9" type="qdm"/></relationalOp></setOp></subTree><subTree displayName="Union of MedRsnForNoPar MedRsnForNotAdmPar LTET 1d SAS Occ A ED LTET1hr" qdmVariable="false" uuid="08B70C77-BCAE-4339-979A-22ED2DECC1D4"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><setOp displayName="Union" type="union"><subTreeRef displayName="MedicationReasonForNoParenteralAnticoagulant" id="CFDB1DA3-3B3A-4F97-8E50-CFF72600B8F5" type="subTree"/><subTreeRef displayName="MedicationReasonForNotAdministeringParenteralAnticoagulantDose" id="88813EB0-DEE1-4F31-B3F2-C9E3423C1803" type="subTree"/></setOp><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></subTree><subTree displayName="Union of MedRsnForNoPar MedRsnForNotAdmPar LTET 1d SAS Occ A EncIP" qdmVariable="false" uuid="BC95143B-2290-4985-9EE8-10A0C7523166"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><setOp displayName="Union" type="union"><subTreeRef displayName="MedicationReasonForNoParenteralAnticoagulant" id="CFDB1DA3-3B3A-4F97-8E50-CFF72600B8F5" type="subTree"/><subTreeRef displayName="MedicationReasonForNotAdministeringParenteralAnticoagulantDose" id="88813EB0-DEE1-4F31-B3F2-C9E3423C1803" type="subTree"/></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp></subTree><subTree displayName="Union of MedRsnForNoPar MedRsnForNotAdmPar LTET 1d SAS VTEtest during EDvis" qdmVariable="false" uuid="62649831-AF0C-477A-8D33-2DE2D0D3FF49"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><setOp displayName="Union" type="union"><subTreeRef displayName="MedicationReasonForNoParenteralAnticoagulant" id="CFDB1DA3-3B3A-4F97-8E50-CFF72600B8F5" type="subTree"/><subTreeRef displayName="MedicationReasonForNotAdministeringParenteralAnticoagulantDose" id="88813EB0-DEE1-4F31-B3F2-C9E3423C1803" type="subTree"/></setOp><subTreeRef displayName="Occ A Diag Study Perf VTE Diag Test starts during Occ A ED Visit" id="B2B30E99-1008-4355-A921-B128D0EF1322" type="subTree"/></relationalOp></subTree><subTree displayName="Union of MedRsnForNoPar MedRsnForNotAdmPar LTET 1d SAS VTEtest during EncIP" qdmVariable="false" uuid="1FA9ABF2-2B65-4CFC-A9D0-5B812FDA057B"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><setOp displayName="Union" type="union"><subTreeRef displayName="MedicationReasonForNoParenteralAnticoagulant" id="CFDB1DA3-3B3A-4F97-8E50-CFF72600B8F5" type="subTree"/><subTreeRef displayName="MedicationReasonForNotAdministeringParenteralAnticoagulantDose" id="88813EB0-DEE1-4F31-B3F2-C9E3423C1803" type="subTree"/></setOp><subTreeRef displayName="Occ A Diag Study Perf VTE Diag Test during Occ A EncIP" id="145B9987-7FDE-44E0-B94E-BBD9B729E12A" type="subTree"/></relationalOp></subTree><subTree displayName="Union of OralFactorXa starts during OccA EncIP ED Visit SAS OccA VTE Diag" qdmVariable="false" uuid="C899BE28-4366-4B89-93BA-277E65FFF080"><relationalOp displayName="Starts After Start Of" type="SAS"><setOp displayName="Union" type="union"><relationalOp displayName="Starts During" type="SDU"><setOp displayName="Union" type="union"><elementRef displayName="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment : Medication, Administered" id="40280381-3d27-5493-013d-3a92ba303cbb" type="qdm"/><elementRef displayName="Dabigatran : Medication, Administered" id="c724cfec-61e4-428b-b01d-741fa1093866" type="qdm"/></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><setOp displayName="Union" type="union"><elementRef displayName="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment : Medication, Administered" id="40280381-3d27-5493-013d-3a92ba303cbb" type="qdm"/><elementRef displayName="Dabigatran : Medication, Administered" id="c724cfec-61e4-428b-b01d-741fa1093866" type="qdm"/></setOp><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></setOp><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/></relationalOp></subTree><subTree displayName="Intersection OccA Inpt Enc sat any Dx VTE_OB VTE" qdmVariable="false" uuid="E627110F-8CF5-4A7B-8581-B2AAC346FAE8"><setOp displayName="Intersection" type="intersection"><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/><functionalOp displayName="Satisfies Any" type="SATISFIES ANY"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="33001d7b-e7c2-4ef8-8f92-04fb286aeafb" mode="Value Set" name="diagnosis" qdmUUID="32a33692-f7c9-42b4-8611-18dbd8cc84b0"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" type="qdm"><attribute attrUUID="bfb76898-3287-44d7-85f0-21b74b50bca4" mode="Value Set" name="diagnosis" qdmUUID="099698f0-d814-413b-a40a-393593be2e17"/></elementRef></functionalOp></setOp></subTree><subTree displayName="First OccA Dx Study VTE Diag Test sat all result Confirmed sat any 3 timing" qdmVariable="false" uuid="B3A1FB77-1972-4536-BA26-277C52984B68"><functionalOp displayName="First" type="FIRST"><functionalOp displayName="Satisfies All" type="SATISFIES ALL"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"><attribute attrUUID="42a0a9bc-203a-49ee-81cc-e911848ee098" mode="Value Set" name="result" qdmUUID="40280381-3cd1-4954-013c-f32c3ab80cb9"/></elementRef><functionalOp displayName="Satisfies Any" type="SATISFIES ANY"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 4 days Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="days"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="EC8AD17C-445E-40BA-B6F0-882B4537047E" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 4 days Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="days"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" type="qdm"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWSO Occ A EncIP" id="21BCFFC9-3A52-49D5-AA92-8A3608FA874D" type="subTree"/></relationalOp></functionalOp></functionalOp></functionalOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 1" type="initialPopulation" uuid="3D8523FD-8C5D-4AB6-B6C8-F36A34C3E633"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GTET 18 years at Occ A EncIP" id="500739A7-45F8-404D-BC27-D96B3DF61AB6" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="Intersection OccA Inpt Enc sat any Dx VTE_OB VTE" id="E627110F-8CF5-4A7B-8581-B2AAC346FAE8" type="subTree"/><subTreeRef displayName="DxVTE variable starts during Occ A EncIP" id="E88B40CF-48AE-447A-B453-98F679BA6016" type="subTree"/><subTreeRef displayName="DxVTE variable starts during ED visit LTET 1hr EBOCW OccA Inpt variable" id="63D2B97D-8934-4008-A3C0-63B61D2B20EE" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="9AA35456-E709-4417-A3BB-19007E9C142B"><logicalOp displayName="AND" type="and"><subTreeRef displayName="First OccA Dx Study VTE Diag Test sat all result Confirmed sat any 3 timing" id="B3A1FB77-1972-4536-BA26-277C52984B68" type="subTree"/><subTreeRef displayName="Med Adm Warfarin sat any starts during Occ A EncIP starts during ED EBS IP" id="EB09CF1C-D186-4066-9D69-C9ADE3663883" type="subTree"/></logicalOp></clause><clause displayName="Denominator Exclusions 1" type="denominatorExclusions" uuid="43F62EAF-4210-49DA-833D-F58BB3085184"><logicalOp displayName="OR" type="or"><subTreeRef displayName="InterventionComfortMsrs starts during Occ A EncIP" id="741AE926-174D-44F6-87FE-6E6A2169C518" type="subTree"/><subTreeRef displayName="InterventionComfortMsrs starts during Occ A ED Visit" id="9A2FA752-2C19-4955-A1C3-16982A14EB8E" type="subTree"/><subTreeRef displayName="Intersection of OccA EncIP EncPerf Enc IP sat any DC statuses" id="644705E0-1F14-4EB5-B68F-FC099CF937C9" type="subTree"/></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="FC75CCAE-3091-4350-A4F5-D1E64BAB6242"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="FIRST Union of MedWar st dur EncIP ED Visit GTET 4d SBS MOST RECENT Union" id="93F8D495-6B7A-42E1-ADBB-E26F90B5A6AE" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="Lab Test Perf INR result GTET 2 LTET 1d SAS OccA Med Adm Parent" id="539F3E7F-C806-4BB8-8BC9-DA2E13D4648C" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Lab Test Perf INR result LT 2 LTET 1d SAS OccA Med Adm Parenter" id="E124972F-CCA1-4B61-9CEF-6533915448C0" type="subTree"/><subTreeRef displayName="Union of Med DC ParenAnti MedRsnForNoParAntiDC starts during EncIP SAS" id="C201AF97-68E1-4E02-B6CB-E40698C800C8" type="subTree"/></logicalOp><subTreeRef displayName="Dx Thrombocytopenia LTET 1 d SAS MOST RECENT Med Adm Parenteral Anti" id="4040A75C-C4EF-4C11-ADA7-9C1853192D70" type="subTree"/></logicalOp></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="FIRST Union of MedWar starts during EncIP ED LT 4d SBS MRECENT Union Med" id="216AB0CC-F366-4AA4-858B-94C801E8CCD3" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="Union of Med DC ParenAnti MedRsnForNoParAntiDC starts during EncIP SAS" id="C201AF97-68E1-4E02-B6CB-E40698C800C8" type="subTree"/><subTreeRef displayName="Dx Thrombocytopenia LTET 1 d SAS MOST RECENT Med Adm Parenteral Anti" id="4040A75C-C4EF-4C11-ADA7-9C1853192D70" type="subTree"/></logicalOp></logicalOp><subTreeRef displayName="Union of MedRsnForNoPar MedRsnForNotAdmPar LTET 1d SAS VTEtest during EncIP" id="1FA9ABF2-2B65-4CFC-A9D0-5B812FDA057B" type="subTree"/><subTreeRef displayName="Union of MedRsnForNoPar MedRsnForNotAdmPar LTET 1d SAS VTEtest during EDvis" id="62649831-AF0C-477A-8D33-2DE2D0D3FF49" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Occ A Diag Study Perf VTE Diag Test LTET 4d SBS Occ A EncIP" id="9D361F6D-83AB-4854-80E4-3216E09C2909" type="subTree"/><subTreeRef displayName="Union of MedRsnForNoPar MedRsnForNotAdmPar LTET 1d SAS Occ A EncIP" id="BC95143B-2290-4985-9EE8-10A0C7523166" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="OccA DiagStudyPerf VTE Diag Test LTET 4d SBS Occ A ED LTET 1hr EBOCWSO Inpt" id="AA830D78-2FB0-4089-A875-F60B75643F8C" type="subTree"/><subTreeRef displayName="Union of MedRsnForNoPar MedRsnForNotAdmPar LTET 1d SAS Occ A ED LTET1hr" id="08B70C77-BCAE-4339-979A-22ED2DECC1D4" type="subTree"/></logicalOp><subTreeRef displayName="Union of OralFactorXa starts during OccA EncIP ED Visit SAS OccA VTE Diag" id="C899BE28-4366-4B89-93BA-277E65FFF080" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="e0749bb6-a4d3-4602-b5b9-99ea34ca2a16"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="098dd6cf-977d-4bb6-ac54-068be21b8c52"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="48221df7-1854-4e75-8ced-f239acf00821"/></group></measureGrouping><elementLookUp><qdm datatype="Patient Characteristic Birthdate" id="54cf2ec8-67b3-4707-b38c-cbe341177767" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="54cf2ec8-67b3-4707-b38c-cbe341177767" version="1.0"/><qdm datatype="Intervention, Order" id="f04dbcdd-fbb8-43d2-b8a7-66d008530eeb" name="Comfort Measures" oid="1.3.6.1.4.1.33895.1.3.0.45" suppDataElement="false" taxonomy="SNOMEDCT" uuid="f04dbcdd-fbb8-43d2-b8a7-66d008530eeb" version="1.0"/><qdm datatype="Intervention, Performed" id="f5ab7743-11b1-4f73-99d4-87dfcfd859d3" name="Comfort Measures" oid="1.3.6.1.4.1.33895.1.3.0.45" suppDataElement="false" taxonomy="SNOMEDCT" uuid="f5ab7743-11b1-4f73-99d4-87dfcfd859d3" version="1.0"/><qdm datatype="Medication, Administered" id="c724cfec-61e4-428b-b01d-741fa1093866" name="Dabigatran" oid="2.16.840.1.113762.1.4.1110.4" suppDataElement="false" taxonomy="RXNORM" uuid="c724cfec-61e4-428b-b01d-741fa1093866" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013c-f32c3ab70caa" name="Discharge To Acute Care Facility" oid="2.16.840.1.113883.3.117.1.7.1.87" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013c-f32c3ab70caa" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013c-f32c3ab60c9e" name="Discharged to Health Care Facility for Hospice Care" oid="2.16.840.1.113883.3.117.1.7.1.207" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013c-f32c3ab60c9e" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013c-f32c3ab60c9f" name="Discharged to Home for Hospice Care" oid="2.16.840.1.113883.3.117.1.7.1.209" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013c-f32c3ab60c9f" version="1"/><qdm datatype="Encounter, Performed" id="65446d24-a0d1-4ce5-940a-419a95bfff23" name="Emergency Department Visit" oid="2.16.840.1.113883.3.117.1.7.1.292" suppDataElement="false" taxonomy="SNOMEDCT" uuid="65446d24-a0d1-4ce5-940a-419a95bfff23" version="1.0"/><qdm datatype="Encounter, Performed" id="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" name="Encounter Inpatient" oid="2.16.840.1.113883.3.666.5.307" suppDataElement="false" taxonomy="SNOMEDCT" uuid="c75eb7cb-a1ff-470f-a9e3-e0d0df697dcb" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3cd1-4954-013c-f32c3ab60c92" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3cd1-4954-013c-f32c3ab60c92" version="1"/><qdm datatype="Patient Characteristic Expired" id="35e8170c-446e-4b19-970b-71d20a574bed" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="35e8170c-446e-4b19-970b-71d20a574bed" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Laboratory Test, Performed" id="40280381-3cd1-4954-013c-f32c3ab60c9d" name="INR" oid="2.16.840.1.113883.3.117.1.7.1.213" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3cd1-4954-013c-f32c3ab60c9d" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013c-f32c3ab70cab" name="Left Against Medical Advice" oid="2.16.840.1.113883.3.117.1.7.1.308" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013c-f32c3ab70cab" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3cd1-4954-013c-f32c3ab70ca1" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3cd1-4954-013c-f32c3ab70ca1" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013c-f32c3ab70ca6" name="Medical Reason" oid="2.16.840.1.113883.3.117.1.7.1.473" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013c-f32c3ab70ca6" version="1"/><qdm datatype="Diagnosis" id="c81556a5-e3f3-4c14-a115-e28ba756a517" name="Obstetrics VTE" oid="2.16.840.1.113883.3.117.1.7.1.264" suppDataElement="false" taxonomy="Grouping" uuid="c81556a5-e3f3-4c14-a115-e28ba756a517" version="1.0"/><qdm datatype="attribute" id="099698f0-d814-413b-a40a-393593be2e17" name="Obstetrics VTE" oid="2.16.840.1.113883.3.117.1.7.1.264" suppDataElement="false" taxonomy="Grouping" uuid="099698f0-d814-413b-a40a-393593be2e17" version="1.0"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3cd1-4954-013c-f32c3ab60c90" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3cd1-4954-013c-f32c3ab60c90" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-3a92ba303cbb" name="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" oid="2.16.840.1.113883.3.117.1.7.1.134" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-3a92ba303cbb" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Discharge" id="40280381-3cd1-4954-013c-f32c3ab80cbe" name="Parenteral Anticoagulant" oid="2.16.840.1.113883.3.117.1.7.1.266" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3cd1-4954-013c-f32c3ab80cbe" version="1"/><qdm datatype="Medication, Administered" id="e60a430e-e701-4aab-86a0-8c6948476ef9" instance="Occurrence A" name="Parenteral Anticoagulant" oid="2.16.840.1.113883.3.117.1.7.1.266" suppDataElement="false" taxonomy="RXNORM" uuid="e60a430e-e701-4aab-86a0-8c6948476ef9" version="1.0"/><qdm datatype="Medication, Order" id="65a58dbd-4e61-430f-8ba0-cc582ae653c3" name="Parenteral anticoagulant ingredient specific" oid="2.16.840.1.113762.1.4.1021.4" suppDataElement="false" taxonomy="RXNORM" uuid="65a58dbd-4e61-430f-8ba0-cc582ae653c3" version="1.0"/><qdm datatype="Medication, Discharge" id="b6e95aa0-55d9-4978-84dd-2e941614a65a" name="Parenteral anticoagulant ingredient specific" oid="2.16.840.1.113762.1.4.1021.4" suppDataElement="false" taxonomy="RXNORM" uuid="b6e95aa0-55d9-4978-84dd-2e941614a65a" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013c-f32c3ab80cb2" name="Patient Expired" oid="2.16.840.1.113883.3.117.1.7.1.309" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013c-f32c3ab80cb2" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013c-f32c3ab70ca7" name="Patient Refusal" oid="2.16.840.1.113883.3.117.1.7.1.93" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013c-f32c3ab70ca7" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3cd1-4954-013c-f32c3ab60c93" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3cd1-4954-013c-f32c3ab60c93" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3cd1-4954-013c-f32c3ab60c91" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3cd1-4954-013c-f32c3ab60c91" version="1"/><qdm datatype="Diagnosis" id="3caf509c-8833-48da-a585-ee72b0041c1a" name="Thrombocytopenia" oid="2.16.840.1.113762.1.4.1045.45" suppDataElement="false" taxonomy="Grouping" uuid="3caf509c-8833-48da-a585-ee72b0041c1a" version="1.0"/><qdm datatype="Diagnosis" id="aedc882e-f4cc-4e9c-afba-dde0ea78e4b3" name="Venous Thromboembolism" oid="2.16.840.1.113883.3.117.1.7.1.279" suppDataElement="false" taxonomy="Grouping" uuid="aedc882e-f4cc-4e9c-afba-dde0ea78e4b3" version="1.0"/><qdm datatype="attribute" id="32a33692-f7c9-42b4-8611-18dbd8cc84b0" name="Venous Thromboembolism" oid="2.16.840.1.113883.3.117.1.7.1.279" suppDataElement="false" taxonomy="Grouping" uuid="32a33692-f7c9-42b4-8611-18dbd8cc84b0" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013c-f32c3ab80cb9" name="VTE Confirmed" oid="2.16.840.1.113883.3.117.1.7.1.407" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013c-f32c3ab80cb9" version="1"/><qdm datatype="Diagnostic Study, Performed" id="3bb72fd7-f63b-47c6-8450-82847c15c424" instance="Occurrence A" name="VTE Diagnostic Test" oid="2.16.840.1.113883.3.117.1.7.1.276" suppDataElement="false" taxonomy="Grouping" uuid="3bb72fd7-f63b-47c6-8450-82847c15c424" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb5" name="Warfarin" oid="2.16.840.1.113883.3.117.1.7.1.232" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3cd1-4954-013c-f32c3ab80cb5" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3cd1-4954-013c-f32c3ab80cb4" name="Parenteral Anticoagulant" oid="2.16.840.1.113883.3.117.1.7.1.266" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3cd1-4954-013c-f32c3ab80cb4" version="1"/><qdm datatype="Diagnostic Study, Performed" id="641f0acb-ff2e-4a3a-85de-23dd7827fa7c" name="VTE Diagnostic Test" oid="2.16.840.1.113883.3.117.1.7.1.276" suppDataElement="false" taxonomy="Grouping" uuid="641f0acb-ff2e-4a3a-85de-23dd7827fa7c" version="1.0"/></elementLookUp></measure>